Crystal Structure of the Unliganded Alkaline Protease from Pseudomonas Aeruginosa IF03O8O and Its Conformational Changes on Ligand Binding 1

Total Page:16

File Type:pdf, Size:1020Kb

Crystal Structure of the Unliganded Alkaline Protease from Pseudomonas Aeruginosa IF03O8O and Its Conformational Changes on Ligand Binding 1 J. Biochem. 118, 474-479 (1995) Crystal Structure of the Unliganded Alkaline Protease from Pseudomonas aeruginosa IF03O8O and Its Conformational Changes on Ligand Binding 1 Hideyuki Miyatake,* Yasuo Hata,*,2 Tomomi Fujii,* Kensaku Hamada,•õ Kazuyuki Morihara,•ö and Yukiteru Katsube * Institute for Chemical Research , Kyoto University, Uji, Kyoto 611; •õFaculty of Science, Shimane University, Matsue, Shimane 690; •öInstitute for Applied Life Science, University of East Asia, 2-1 Ichinomiya-Gakuen-cho, Shimonoseki, Yamaguchi 751; and Institute for Protein Research, Osaka University, Suita, Osaka 565 Received for publication, May 31, 1995 The crystal structure of the unliganded alkaline protease from Pseudomonas aeruginosa IF03080 has been determined at 2.0 A resolution by the X-ray method. The enzyme consists of N-terminal catalytic and C-terminal ƒÀ-helix domains. On structural comparison between the present unliganded enzyme and structurally-known liganded enzyme, some structural changes were observed around the active site. In the unliganded enzyme, Y216 serves as the fifth ligand for the active site zinc ion. On ligand binding, Y216 may move to form a hydrogen-bond with the carbonyl oxygen of the P1 residue of a ligand peptide. D191 in the flexible loop, Y190 to D196, over the active site cleft forms hydrogen-bonds with the backbone atoms of the P1 and P2 residues of the ligand to close the entrance of the cleft. The water molecule which is the fourth ligand for the zinc ion is replaced by the carbonyl oxygen of the P1 residue. These structural changes around the active site may reflect the substrate-binding mode during the enzymatic reaction. Key words: alkaline protease, ƒÀ-helix, crystal structure, metalloprotease, Pseudomonas aeruginosa. Pseudomonas aeruginosa is well known to secrete two alkaline protease. Neutral metalloproteases such as ther metalloproteases: a 50 kDa alkaline protease and a 33 kDa molysin and P. aeruginosa elastase, which are more com elastase, which belong to the serralysin and thermolysin mon than alkaline metalloproteases, are typical "N(NH2) families, respectively. These enzymes were originally type" enzymes which hydrolyze the peptide bonds of isolated from P. aeruginosa IF03080 and IF03455, and certain amino acid residues on the amino group side through characterized as zinc-dependent metalloproteases by specific recognition. On the contrary, a P. aeruginosa Morihara et al. (1-3). In particular, the alkaline protease alkaline protease is a "C (COOH) -type" endoprotease which from P. aeruginosa has been paid much attention in the digests its substrate on the carboxyl side of certain amino medical field for the development of anti-infection agents acid residues (13), and has a hydrophobic binding site (S2') against the bacterium (4). The enzyme is composed of a in addition to the major recognition site (S1) for Arg or polypeptide chain and one catalytic zinc atom, and requires probably Lys (14). Thus, the alkaline protease is an Arg (or several calcium ions for stabilization of its folding (2). The Lys)-specific C-type metalloprotease, although its sub amino acid sequences of 470 residues for P. aeruginosa strate specificity is relatively broad (12, 15). The patho alkaline proteases have been deduced from the DNA logical aspects of the alkaline protease have been extensive sequences of its strains, IF03455 (5) and PA01 (6). The ly investigated already. The enzyme exhibits the potential crystal structure of the alkaline protease from P. aeru anti-coagulant capacity to hydrolyze natural substrates of ginosa was determined using a complex of the enzyme with plasmin, such as fibrin and fibrinogen, with similar specific a mixture of tetrapeptide products (7). The structure was activities to plasmin (13). From these properties of the used to determine the crystal structure of the 50 kDa alkaline protease from P. aeruginosa , it is inferred that the metalloprotease from Serratia marcescens (8), a member enzyme may play a key role in infection of host cells by the of the serralysin family (9-11). From biochemical studies bacterium through the inactivation of various physiological on the catalysis by a P. aeruginosa alkaline protease, it is activators such as some complement components , im well known that the potential catalytic capability of the munoglobulins A and G, and many protease inhibitors (16). enzyme is optimum in the alkaline pH range of 8 to 10 (1, In order to elucidate the characteristic mechanism of its 12). The alkaline optimum pH is characteristic of the catalysis, and to determine the reasons for its alkaline optimum pH and the C(COOH)-type recognition on sub 1 This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas (No. 06235204) from the Ministry of strate cleavage, we have determined the crystal structure Education, Science and Culture of Japan. of the alkaline protease from P. aeruginosa IF03080 by the 2 To whom correspondence should be addressed . Phone: +81-774-32 X-ray diffraction method . Here we report the three-dimen 3111 (Ext. 2159), Fax: +81-774-33-1247 sional structure of the unliganded alkaline protease from P. 474 J. Biochem. Unliganded Alkaline Protease Structure 475 aeruginosa determined at 2,0 A resolution, and the struc technique (19). The solvent-flattened map was good enough tural differences between the unliganded and liganded to follow the entire main-chain folding and most of the forms of the enzyme. side-chain orientations of the enzyme molecule. An initial A lyophilized sample of the alkaline protease from P. model of the enzyme was built with the program package, aeruginosa IFO3080, which was a gift from Nagase Bio TURBO-FRODO (20), on a computer graphics system, chemical, was subjected to crystallization without further IRIS Indigo Elan. The initial crystallographic R value was purification. Crystallization trials were conducted using the 43.5% for 16,182 independent reflections [I>3ƒÐ(I)] hanging drop vapor diffusion method. Small crystals were within the resolution of 10.0 to 2.8A. The model was obtained at 25•‹C using a precipitant solution of 6% (w/v) refined by means of simulated annealing techniques using polyethylene glycol 6000 (50mM acetate buffer including 1 the molecular dynamics program, X-PLOR (21, 22), in mM NaN3, pH 5.6). For the crystallization, the droplets stalled on a CRAY Y-MP2E/264 supercomputer. After were prepared by adding 2.5,ƒÊl of the precipitant solution several cycles of refinement, manual rebuilding of the to an equal volume of a 2% protein solution (pH 7.0) model was carried out using 2Fo -Fc and Fo -Fc maps. The including 5mM CaCl2 and 1mM NaN3. The macroseeding resolution was gradually increased to 2.0 A during iteration technique was effective for growing the small crystals to a of refinement and rebuilding. The total numbers of 335 size (1.0 x 0.6 x 0.3mm) large enough for X-ray experi water molecules and 8 calcium ions were included for the ments. The prismatic crystals have the orthorhombic space further refinement below 2.5 A resolution. The final model group, P2,212,, with cell dimensions of a=77.16, b= has an R factor of 19.8% for 33,698 independent reflections 176.69, and c=51.12 A. They contain four enzyme mole [I > 2ƒÐ (I), 80.0% complete] within the resolution of 8.0 to cules in the unit cell, and exhibit a Vm value of 3.56 A3/Da, 2.0 A. The root-mean-square (r.m.s) deviations from ideal which corresponds to the solvent content, 66%, in the bond distances and angles were 0.009 A and 1.58•‹, respec crystals. Three kinds of isomorphous heavy-atom deriva tively. The model exhibits a reasonable conformation with tive crystals were prepared by soaking the native crystals excellent geometry. The model was inspected with the in heavy-atom solutions of 15mM CH3HgC1, for 3 days, 2.5 program, PROCHECK (23). All residues were observed in mM HgCl2, for 1 day, and 1mM UO2(CH3COO)2, for 1 day, the allowed region of the Ramachandran plot, and 87.6% of respectively. the total residues lay in the most favored region. The All diffraction intensity data were collected using the coordinates of the final model will be deposited in the synchrotron radiation X-ray source (wavelength = 1.00 Brookhaven Protein Data Bank. A) at the Photon Factory of the National Laboratory for Stereoscopic drawings and a folding diagram of the High Energy Physics, Tsukuba, Japan. X-ray diffraction alkaline protease are shown in Figs. 1 and 2, respectively. patterns were recorded on Fuji-imaging plates with a The enzyme molecule has an elongated ellipsoidal shape screenless Weissenberg camera at the BL6A2 station. Two with approximate dimensions of 90 X 42 x 35 A. Its struc native crystals were mounted with the crystallographic b* ture comprises two structurally distinct domains: N and and c* axes parallel to the spindle axis, respectively, and C-terminal domains. the derivative crystals with the c* axis parallel to the Apart from the a -helix comprising the first 17 residues, spindle. The intensity data were processed with the pro which is associated with the C-terminal domain, the N gram, WEIS (17), and calculations of phases and electron terminal domain, residues 18-250, is a catalytic domain density maps were carried out with the program, PHASES with one zinc ion in the active center and shares a basically (18). The statistics for data collection and phase calculation common folding topology with other zinc metalloendopro are summarized in Table I. teases, as suggested by Blundell (24). The catalytic domain A 2.8 A resolution electron density map of the alkaline has an open-sandwich topology, as shown in Fig. 2, in which protease calculated by the isomorphous replacement two ƒ¿-helices (ƒ¿5 and ƒ¿6) lie against a twisted mixed method was modified by means of the solvent-flattening ƒÀ-sheet of five strands (ƒÀ3-ƒÀ7).
Recommended publications
  • Biochemical Characterization of Human Matrix Metalloproteinases and Their Newly Designed Inhibitors Related to Stroke Qiang Cao
    Florida State University Libraries Electronic Theses, Treatises and Dissertations The Graduate School 2010 Biochemical Characterization of Human Matrix Metalloproteinases and Their Newly Designed Inhibitors Related to Stroke Qiang Cao Follow this and additional works at the FSU Digital Library. For more information, please contact [email protected] THE FLORIDA STATE UNIVERSITY COLLEGE OF ARTS AND SCIENCES BIOCHEMICAL CHARACTERIZATION OF HUMAN MATRIX METALLOPROTEINASES AND THEIR NEWLY DESIGNED INHIBITORS RELATED TO STROKE By QIANG CAO A Dissertation submitted to the Department of Chemistry and Biochemistry in partial fulfillment of the requirements for the degree of Doctor of Philosophy Degree Awarded: Fall Semester, 2010 The members of the committee approve the dissertation of Qiang Cao defended on July 14, 2010. Qing-Xiang Amy Sang Professor Directing Dissertation Yan-Chang Wang University Representative Hong Li Committee Member Igor Alabugin Committee Member Approved: Joseph B. Schlenoff, Chair, Department of Chemistry and Biochemistry The Graduate School has verified and approved the above-named committee members. ii This dissertation is dedicated to my parents, Shi-De Cao & Mu-Dan Li. iii ACKNOWLEDGEMENTS There are many people to thank for their support and guidance during the past years. My wife, Juan Zhou, has shown a great deal of patience and personal support through difficult times. Professor Qing-Xiang Amy Sang has provided outstanding scientific guidance and truly developed my interest in cancer research and cardiovascular disease research. A special thanks is given to Drs. Martin Schwartz, Yonghao Jin and Wei Yang for the many discussions about inhibitor interactions the synthesis and modeling of the compounds. I especially thank Mark Dru Roycik for his help on English writing and organizing through the past years and Douglas R.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Transcription Factor Eepr Is Required for Serratia Marcescens Host Proinflammatory Response by Corneal Epithelial Cells
    antibiotics Article Transcription Factor EepR Is Required for Serratia marcescens Host Proinflammatory Response by Corneal Epithelial Cells Kimberly M. Brothers , Stephen A. K. Harvey and Robert M. Q. Shanks * Charles T. Campbell Ophthalmic Microbiology Laboratory, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA; [email protected] (K.M.B.); [email protected] (S.A.K.H.) * Correspondence: [email protected]; Tel.: +1-412-647-3537 Abstract: Relatively little is known about how the corneal epithelium responds to vision-threatening bacteria from the Enterobacterales order. This study investigates the impact of Serratia marcescens on corneal epithelial cell host responses. We also investigate the role of a bacterial transcription factor EepR, which is a positive regulator of S. marcescens secretion of cytotoxic proteases and a hemolytic surfactant. We treated transcriptomic and metabolomic analysis of human corneal limbal epithelial cells with wild-type bacterial secretomes. Our results show increased expression of proinflammatory and lipid signaling molecules, while this is greatly altered in eepR mutant-treated corneal cells. Together, these data support the model that the S. marcescens transcription factor EepR is a key regulator of host-pathogen interactions, and is necessary to induce proinflammatory chemokines, cytokines, and lipids. Keywords: bacterial infection; Serratia marcescens; transcription factor; keratitis; ocular surface; epithelium; cornea; metabolomics Citation: Brothers, K.M.; Harvey, S.A.K.; Shanks, R.M.Q. Transcription Factor EepR Is Required for Serratia marcescens Host Proinflammatory 1. Introduction Response by Corneal Epithelial Cells. The cornea, the transparent, anterior layer of the eye, is essential for vision and pro- Antibiotics 10 2021, , 770.
    [Show full text]
  • Functional and Structural Insights Into Astacin Metallopeptidases
    Biol. Chem., Vol. 393, pp. 1027–1041, October 2012 • Copyright © by Walter de Gruyter • Berlin • Boston. DOI 10.1515/hsz-2012-0149 Review Functional and structural insights into astacin metallopeptidases F. Xavier Gomis-R ü th 1, *, Sergio Trillo-Muyo 1 Keywords: bone morphogenetic protein; catalytic domain; and Walter St ö cker 2, * meprin; metzincin; tolloid; zinc metallopeptidase. 1 Proteolysis Lab , Molecular Biology Institute of Barcelona, CSIC, Barcelona Science Park, Helix Building, c/Baldiri Reixac, 15-21, E-08028 Barcelona , Spain Introduction: a short historical background 2 Institute of Zoology , Cell and Matrix Biology, Johannes Gutenberg University, Johannes-von-M ü ller-Weg 6, The fi rst report on the digestive protease astacin from the D-55128 Mainz , Germany European freshwater crayfi sh, Astacus astacus L. – then termed ‘ crayfi sh small-molecule protease ’ or ‘ Astacus pro- * Corresponding authors tease ’ – dates back to the late 1960s (Sonneborn et al. , 1969 ). e-mail: [email protected]; [email protected] Protein sequencing by Zwilling and co-workers in the 1980s did not reveal homology to any other protein (Titani et al. , Abstract 1987 ). Shortly after, the enzyme was identifi ed as a zinc met- allopeptidase (St ö cker et al., 1988 ), and other family mem- The astacins are a family of multi-domain metallopepti- bers emerged. The fi rst of these was bone morphogenetic β dases with manifold functions in metabolism. They are protein 1 (BMP1), a protease co-purifi ed with TGF -like either secreted or membrane-anchored and are regulated growth factors termed bone morphogenetic proteins due by being synthesized as inactive zymogens and also by co- to their capacity to induce ectopic bone formation in mice localizing protein inhibitors.
    [Show full text]
  • Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases
    Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases Alan J. Barrett Neil D. Rawlings J. Fred Woessner Editor biographies xxi Contributors xxiii Preface xxxi Introduction ' Abbreviations xxxvii ASPARTIC PEPTIDASES Introduction 1 Aspartic peptidases and their clans 3 2 Catalytic pathway of aspartic peptidases 12 Clan AA Family Al 3 Pepsin A 19 4 Pepsin B 28 5 Chymosin 29 6 Cathepsin E 33 7 Gastricsin 38 8 Cathepsin D 43 9 Napsin A 52 10 Renin 54 11 Mouse submandibular renin 62 12 Memapsin 1 64 13 Memapsin 2 66 14 Plasmepsins 70 15 Plasmepsin II 73 16 Tick heme-binding aspartic proteinase 76 17 Phytepsin 77 18 Nepenthesin 85 19 Saccharopepsin 87 20 Neurosporapepsin 90 21 Acrocylindropepsin 9 1 22 Aspergillopepsin I 92 23 Penicillopepsin 99 24 Endothiapepsin 104 25 Rhizopuspepsin 108 26 Mucorpepsin 11 1 27 Polyporopepsin 113 28 Candidapepsin 115 29 Candiparapsin 120 30 Canditropsin 123 31 Syncephapepsin 125 32 Barrierpepsin 126 33 Yapsin 1 128 34 Yapsin 2 132 35 Yapsin A 133 36 Pregnancy-associated glycoproteins 135 37 Pepsin F 137 38 Rhodotorulapepsin 139 39 Cladosporopepsin 140 40 Pycnoporopepsin 141 Family A2 and others 41 Human immunodeficiency virus 1 retropepsin 144 42 Human immunodeficiency virus 2 retropepsin 154 43 Simian immunodeficiency virus retropepsin 158 44 Equine infectious anemia virus retropepsin 160 45 Rous sarcoma virus retropepsin and avian myeloblastosis virus retropepsin 163 46 Human T-cell leukemia virus type I (HTLV-I) retropepsin 166 47 Bovine leukemia virus retropepsin 169 48
    [Show full text]
  • Anti-Matrix Metalloproteinase-7, N-Terminal of Active Enzyme
    ANTI-MATRIX METALLOPROTEINASE-7 (MMP-7), N-Terminal of active enzyme Developed in Rabbit, Affinity Isolated Antibody Product Number M8808 Product Description development, uterine involution, angiogenesis,4 and Anti-Matrix Meltalloproteinase-7 (MMP-7) is developed tissue remodeling, and in diseases such as multiple in rabbit using a synthetic peptide corresponding to the sclerosis,2, 5 Alzheimer’s,2 malignant gliomas,2 lupus, aminoterminal end of the active enzyme of human arthritis, periodontis, glumerulonephritis, atherosclero- matrix metalloproteinase-7 (matrilysin, PUMP) as sis, tissue ulceration, and in cancer cell invasion and immunogen. The antibody is affinity purified using metastasis.6 Numerous studies have shown that there peptide agarose. is a close association between expression of various members of the MMP family by tumors and their Rabbit Anti-MMP-7 specifically binds to MMP-7 and proliferative and invasive behavior and metastaic does not cross-react with other MMP family members potential. (MMP-1, MMP-2, MMP-3, etc). By immunoblotting against the reduced protein, the antibody reacts with The tissue inhibitors of metalloproteinases (TIMPs) are bands at 28 kDa and 18 kDa (the pro- and active- naturally occurring proteins that specifically inhibit forms, respectively). It also reacts with non-reduced matrix metalloproteinases and regulate extracellular MMP-7. The antibody may be used for immunopre- matrix turnover and tissue remodeling by forming tight- cipitation, immunohistochemistry and ELISA. binding inhibitory complexes with the MMPs. Thus, TIMPs maintain the balance between matrix destruction The matrix metalloproteinases (MMPs) are a family of and formation. An imbalance between MMPs and the at least eighteen secreted and membrane-bound zinc- associated TIMPs may play a significant role in the endopeptidases.
    [Show full text]
  • 10295 2007 245 Article-Web 1..7
    J Ind Microbiol Biotechnol (2007) 34:715–721 DOI 10.1007/s10295-007-0245-1 ORIGINAL PAPER Characterization and role of a metalloprotease induced by chitin in Serratia sp. KCK Hyun-Soo Kim · Peter N. Golyshin · Kenneth N. Timmis Received: 14 June 2007 / Accepted: 9 July 2007 / Published online: 1 August 2007 © Society for Industrial Microbiology 2007 Abstract A metalloprotease induced by chitin in a new bonds between GlcNAc residues [9, 14]. Chitin in crusta- chitinolytic bacterium Serratia sp. Strain KCK was puriWed cean cuticles is associated with protein, inorganic salts and and characterized. Compared with other Serratia enzymes, lipids, and it has been reported that a combination of chitin- it exhibited a rather broad pH activity range (pH 5.0–8.0), ase and protease results in more eYcient degradation of and thermostability. The cognate ORF, mpr, was cloned crustacean cuticles than chitinase alone [20, 21]. and expressed. Its deduced amino acid sequence showed Microbial proteases are classiWed into four groups, high similarity to those of bacterial zinc-binding metallo- according to the catalytic residue functioning in their active proteases and a well-conserved serralysin family motif. sites: serine proteases, cysteine proteases, aspartate prote- Pretreatment of chitin with the Mpr protein promoted chitin ases and metalloproteases [10]. Metalloproteases have the degradation by chitinase A, which suggests that Mpr partic- HEXXH zinc-binding motif and can be further classiWed ipates in, and facilitates, chitin degradation by this microor- into thermolysin, serralysin, and neurotoxin families, ganism. according to the location of the third zinc ligand. Bacteria belonging to the genus Serratia are frequently Keywords Metalloprotease · Chitin · Serratia · Chitinase A found to produce chitinases, and we have recently isolated from the traditional Korean fermented cabbage product kimchi a novel Serratia strain producing a chitinase with Introduction unusually broad substrate, pH activity and thermostability spectra [15].
    [Show full text]
  • Perspectives on Ovarian Cancer Progression
    International Journal of Molecular Sciences Review The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression Ruth M. Escalona 1,2,3, Emily Chan 1, George Kannourakis 3,4, Jock K. Findlay 1,2 and Nuzhat Ahmed 1,2,3,4,* 1 Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC 3052, Australia; [email protected] (R.M.E.); [email protected] (E.C.); jock.fi[email protected] (J.K.F.) 2 The Hudson Institute of Medical Research, Clayton, VIC 3168, Australia 3 Fiona Elsey Cancer Research Institute, Ballarat, VIC 3353, Australia; [email protected] 4 Federation University Australia, Ballarat, VIC 3010, Australia * Correspondence: [email protected]; Tel.: +61-403038387 Received: 19 December 2017; Accepted: 24 January 2018; Published: 2 February 2018 Abstract: Approximately sixty per cent of ovarian cancer patients die within the first five years of diagnosis due to recurrence associated with chemoresistance. The metzincin family of metalloproteinases is enzymes involved in matrix remodeling in response to normal physiological changes and diseased states. Recently, there has been a mounting awareness of these proteinases and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), as superb modulators of cellular communication and signaling regulating key biological processes in cancer progression. This review investigates the role of metzincins and their inhibitors in ovarian cancer. We propose that understanding the metzincins and TIMP biology in ovarian cancer may provide valuable insights in combating ovarian cancer progression and chemoresistance-mediated recurrence in patients. Keywords: metzincins; ovarian cancer; metastasis; matrix metalloproteinases (MMPs); disintegrin and metalloproteinases (ADAMs); ADAM proteases with thrombospondin motifs (ADAMTS); TIMPs 1.
    [Show full text]
  • Targeting the Role of Subtilisin-Like Protease 2 for Inhibition Of
    TARGETING THE ROLE OF SUBTILISIN-LIKE PROTEASE 2 FOR INHIBITION OF ERYTHROCYTE INVASION BY THE MALARIA PARASITE, PLASMODIUM By Daisy del Carmen Colón López A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland 2016 © 2016 Daisy del Carmen Colón López All Rights Reserved Abstract Malaria is a mosquito-harbored infectious disease causing approximately half a million deaths every year around the world. Out of the five Plasmodium species that infect humans, P. falciparum is the deadliest. Despite the relative success in decreasing malaria-related deaths through various efforts, emergence of parasite resistance against antimalarials remains a major challenge. This is mainly because the parasite develops resistance before new effective drugs can become available. In addition, there is no approved vaccine for malaria that will prevent the infection in most groups affected. The protection offered by the malaria vaccine candidate, RTS,S, currently on phase III clinical trials, is less than 40% in children when used along with bed nets and other malaria prevention recommendations. Additional vaccine candidates are needed to provide better protection against malaria. The characterization of molecular targets allows the development of inhibitors against the parasite via rational design, helping to advance the development of vaccine and treatment. Subtilisin-like protease 2 (SUB2) is the only Plasmodium subtilisin playing a direct role during invasion of the red blood cell (RBC), a critical step in malaria parasite development during the asexual, symptom-causing stages. SUB2 merozoite surface sheddase (MeSh) activity is essential for parasite survival and RBC invasion.
    [Show full text]
  • Architecture and Function of Metallopeptidase Catalytic Domains
    Cerdà-Costa et al. 1 !"#$%&'#&("')*+,)-(+#&%.+).-)/'&*00.1'1&%,*2')#*&*03&%#) ,./*%+2) ) 45"%*)6'",786.2&*)9):;)<*=%'")>./%28?@&$)A)) ) ) B".&'.032%2)C*DE)F'1*"&/'+&).-)G&"(#&("*0)H%.0.I3E)J.0'#(0*")H%.0.I3)K+2&%&(&').-) H*"#'0.+*L)6GK6E)H*"#'0.+*)G#%'+#')B*"ME)N'0%O)H(%0,%+IE)#P)H*0,%"%)?'%O*#L)QR8SQE)T8 UVUSV)H*"#'0.+*)WG1*%+X;) ) A)6.""'21.+,'+#'Y)'8/*%0Y)-OI"Z%D/D;#2%#;'2L)1$.+'Y)W[\]X)^\])USU)QV_L)-*OY)W[\]X)^\]) U\])^`^;) ) a$')*(&$."2)2&*&')&$'3)$*=')+.)#./1'&%+I)-%+*+#%*0)%+&'"'2&;) ) b'3c.",2Y)G&"(#&("*0)D%.#$'/%2&"3L)/'&d%+#%+)#0*+L)#*&*03&%#),./*%+2L)*#&%='82%&')#0'-&L) $3,".03&%#)'+d3/'2L)/*&"%O)/'&*00.1".&'*2'2L)*2&*#%+2L)!F!JL)*,*/*032%+2L)2'""*032%+2L) /'&*00.1".&'*2'L)/'&*00.1".&'%+*2';) ! Cerdà-Costa et al. 2 "#$%&"'%! a$')#0'*=*I').-)1'1&%,')D.+,2)D3)/'&*00.1'1&%,*2'2)WJB2X)%2)'22'+&%*0)-.")0%-';)a$'2')(D%e(%&.(2)'+d3/'2) 1*"&%#%1*&')%+)*00)/*f.")1$32%.0.I%#*0)1".#'22'2L)*+,)2.)&$'%"),'"'I(0*&%.+)0'*,2)&.),%2'*2'2)"*+I%+I)-"./)#*+#'") *+,)/'&*2&*2%2L)%+-0*//*&%.+L)*+,)/%#".D%*0)%+-'#&%.+)&.)+'(".0.I%#*0)%+2(0&2)*+,)#*",%.=*2#(0*"),%2.",'"2;)JB2) #0'*=')&$'%")2(D2&"*&'2)c%&$.(&)#.=*0'+&)%+&'"/',%*&')%+)*)2%+I0'82&'1)"'*#&%.+)%+=.0=%+I)*)2.0='+&)/.0'#(0'L)*) I'+'"*0) D*2'P*#%,L) *+,) *) /.+.8) .") ,%+(#0'*") #*&*03&%#) /'&*0) 2%&';) J.2&) /.+./'&*00%#) JB2) #./1"%2') *) 2$."&) /'&*08D%+,%+I)/.&%-)WNT<<NXL)c$%#$)%+#0(,'2)&c.)/'&*08D%+,%+I)$%2&%,%+'2)*+,)*)I'+'"*0)D*2'P*#%,)I0(&*/*&'L) *+,)&$'3)*"')I".(1',)%+&.)&$')d%+#%+)&"%D').-)JB2;)a$')0*&&'"),%=%,'2)/*%+03)%+&.)&$')I0(d%+#%+)*+,)/'&d%+#%+) #0*+2;) J'&d%+#%+2) #.+2%2&)
    [Show full text]
  • Tumor Necrosis Factor Alpha Converting Enzyme Inhibition During Acute Colitis in Mice: a Regional Analysis
    BearWorks MSU Graduate Theses Summer 2015 Tumor Necrosis Factor Alpha Converting Enzyme Inhibition during Acute Colitis in Mice: A Regional Analysis Brian Maddox As with any intellectual project, the content and views expressed in this thesis may be considered objectionable by some readers. However, this student-scholar’s work has been judged to have academic value by the student’s thesis committee members trained in the discipline. The content and views expressed in this thesis are those of the student-scholar and are not endorsed by Missouri State University, its Graduate College, or its employees. Follow this and additional works at: https://bearworks.missouristate.edu/theses Part of the Medical Molecular Biology Commons Recommended Citation Maddox, Brian, "Tumor Necrosis Factor Alpha Converting Enzyme Inhibition during Acute Colitis in Mice: A Regional Analysis" (2015). MSU Graduate Theses. 2866. https://bearworks.missouristate.edu/theses/2866 This article or document was made available through BearWorks, the institutional repository of Missouri State University. The work contained in it may be protected by copyright and require permission of the copyright holder for reuse or redistribution. For more information, please contact [email protected]. TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITION DURING ACUTE COLITIS IN MICE: A REGIONAL ANALYSIS A Masters Thesis Presented to The Graduate College of Missouri State University In Partial Fulfillment Of the Requirements for the Degree Master of Science, Cell and Molecular Biology By Brian Maddox July 2015 TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITION DURING ACUTE COLITIS IN MICE: A REGIONAL ANALYSIS Biomedical Sciences Missouri State University, July 2015 Master of Science Brian Maddox ABSTRACT Tumor Necrosis Factor-α Converting Enzyme (TACE) induces active TNFα and may contribute to the development of colitis in humans.
    [Show full text]
  • Peptide Sequence
    Peptide Sequence Annotation AADHDG CAS-L1 AAEAISDA M10.005-stromelysin 1 (MMP-3) AAEHDG CAS-L2 AAEYGAEA A01.009-cathepsin D AAGAMFLE M10.007-stromelysin 3 (MMP-11) AAQNASMW A06.001-nodavirus endopeptidase AASGFASP M04.003-vibriolysin ADAHDG CAS-L3 ADAPKGGG M02.006-angiotensin-converting enzyme 2 ADATDG CAS-L5 ADAVMDNP A01.009-cathepsin D ADDPDG CAS-21 ADEPDG CAS-L11 ADETDG CAS-22 ADEVDG CAS-23 ADGKKPSS S01.233-plasmin AEALERMF A01.009-cathepsin D AEEQGVTD C03.007-rhinovirus picornain 3C AETFYVDG A02.001-HIV-1 retropepsin AETWYIDG A02.007-feline immunodeficiency virus retropepsin AFAHDG CAS-L24 AFATDG CAS-25 AFDHDG CAS-L26 AFDTDG CAS-27 AFEHDG CAS-28 AFETDG CAS-29 AFGHDG CAS-30 AFGTDG CAS-31 AFQHDG CAS-32 AFQTDG CAS-33 AFSHDG CAS-L34 AFSTDG CAS-35 AFTHDG CAS-L36 AGERGFFY Insulin B-chain AGLQRGGG M14.004-carboxypeptidase N AGSHLVEA Insulin B-chain AIDIDG CAS-L37 AIDPDG CAS-38 AIDTDG CAS-39 AIDVDG CAS-L40 AIEHDG CAS-L41 AIEIDG CAS-L42 AIENDG CAS-43 AIEPDG CAS-44 AIEQDG CAS-45 AIESDG CAS-46 AIETDG CAS-47 AIEVDG CAS-48 AIFQGPID C03.007-rhinovirus picornain 3C AIGHDG CAS-49 AIGNDG CAS-L50 AIGPDG CAS-L51 AIGQDG CAS-52 AIGSDG CAS-53 AIGTDG CAS-54 AIPMSIPP M10.051-serralysin AISHDG CAS-L55 AISNDG CAS-L56 AISPDG CAS-57 AISQDG CAS-58 AISSDG CAS-59 AISTDG CAS-L60 AKQRAKRD S08.071-furin AKRQGLPV C03.007-rhinovirus picornain 3C AKRRAKRD S08.071-furin AKRRTKRD S08.071-furin ALAALAKK M11.001-gametolysin ALDIDG CAS-L61 ALDPDG CAS-62 ALDTDG CAS-63 ALDVDG CAS-L64 ALEIDG CAS-L65 ALEPDG CAS-L66 ALETDG CAS-67 ALEVDG CAS-68 ALFQGPLQ C03.001-poliovirus-type picornain
    [Show full text]